Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 206 Records) |
| Query Trace: Schizophrenia and DRD2[original query] |
|---|
| No Effect of Genome-Wide Significant Schizophrenia Risk Variation at the DRD2 Locus on the Allelic Expression of DRD2 in Postmortem Striatum. Molecular neuropsychiatry 2019 11 5 (4): 212-217. Toste Carolina C, Duarte Rodrigo R R, Jeffries Aaron R, Selvackadunco Sashika, Troakes Claire, O'Donovan Michael C, Hill Matthew J, Bray Nicholas |
| Association of the genetic polymorphisms of metabolizing enzymes, transporters, target receptors and their interactions with treatment response to olanzapine in chinese han schizophrenia patients. Psychiatry research 2020 9 293 113470. Yan Pan, Song Mingfen, Gao Bing, Wang Shuqi, Wang Shengdong, Li Jing, Fang Haihong, Wang Chengpeng, Shi Jianf |
| The effect of rs1076560 (DRD2) and rs4680 (COMT) on tardive dyskinesia and cognition in schizophrenia subjects. Psychiatric genetics 2020 Oct 30 (5): 125-135. Punchaichira Toyanji Joseph, Kukshal Prachi, Bhatia Triptish, Deshpande Smita Neelkanth, Thelma B |
| D2 dopamine receptor gene (DRD2) Taq1A (rs1800497) affects bone density. Scientific reports 2020 8 10 (1): 13236. Chiang Ting-I, Lane Hsien-Yuan, Lin Chieh-Hs |
| [Pharmacogenetic aspects of the dopaminergic system in clozapine pharmacodynamics]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2020 120 (7): 134-141. Kravtsov V V, Filippov I A, Vaiman E E, Shnayder N A, Nasyrova R |
| Association of ANKK1 polymorphism with antipsychotic-induced hyperprolactinemia. Human psychopharmacology 2020 May e2737. Fedorenko Olga Yu, Paderina Diana Z, Loonen Anton J M, Pozhidaev Ivan V, Boiko Anastasiia S, Kornetova Elena G, Bokhan Nikolay A, Wilffert Bob, Ivanova Svetlana |
| Synonymous polymorphism rs201256011 in dopamine receptor type 2 gene is associated with schizophrenia and PANSS score in Pakistani population: A first report. International journal of clinical practice 2020 May e13536. Amir Qurat-Ul-Ain, Hanif Farina, Washdev Washdev, Bilwani Fareena, Usman Simjee Shaba |
| Remission Is not Associated with DRD2 rs1800497 and DAT1 rs28363170 Genetic Variants in Male Schizophrenic Patients after 6-months Monotherapy with Olanzapine. Psychiatria Danubina 2020 32 (1): 84-91. Zivkovic Maja, Mihaljevic-Peles Alma, Muck-Seler Dorotea, Sagud Marina, Ganoci Lana, Vlatkovic Suzana, Tudor Lucija, Pivac Nela, Bozina Na |
| Association of Genetic Variants of Dopamine and Serotonin In Schizophrenia. Archives of medical research 2020 Feb 51 (1): 13-20. Zakharyan Roksana, Ghazaryan Hovsep, Kocourkova Lenka, Chavushyan Andranik, Mkrtchyan Artur, Zizkova Veronika, Arakelyan Arsen, Petrek Mart |
| Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2021 Jan 133 111087. Zubiaur Pablo, Soria-Chacartegui Paula, Koller Dora, Navares-Gómez Marcos, Ochoa Dolores, Almenara Susana, Saiz-Rodríguez Miriam, Mejía-Abril Gina, Villapalos-García Gonzalo, Román Manuel, Martín-Vílchez Samuel, Abad-Santos Francis |
| A Novel Variant in Dopamine Receptor Type 2 Gene is Associated with Schizophrenia. Archives of medical research 2020 Nov . Hanif Farina, Amir Qurat-Ul-Ain, Washdev Washdev, Bilwani Fareena, Simjee Shabana Usman, Haque Ze |
| Association of DRD2 gene polymorphisms with schizophrenia in the young Bangladeshi population: A pilot study. Heliyon 2020 Oct 6 (10): e05125. Hussain Md Saddam, Siddiqui Shafayet Ahmed, Mondal Susmita, Millat Md Shalahuddin, Marzan Sadiatul, Uddin Md Giash, Aziz Md Abdul, Alam Md Faruq, Islam Mohammad Safiq |
| Treatment Response and GWAS Risk Allele rs2514218 (C) of the Dopamine D2 Receptor Gene in Inpatients with Schizophrenia. Neuropsychobiology 2021 Sep 1-7. Morozova Margarita A, Lezheiko Tatyana V, Lepilkina Taissia A, Burminskiy Denis S, Potanin Sergey S, Beniashvili Allan G, Rupchev George E, Golimbet Vera |
| Investigating the association between common DRD2/ANKK1 genetic polymorphisms and schizophrenia: a meta-analysis. Journal of genetics 2021 9 100 . Habibzadeh Parham, Nemati Azim, Dastsooz Hassan, Taghipour-Sheshdeh Afsaneh, Mariam Paul Prisho, Sahraian Ali, Ali Faghihi Mohamm |
| Impact on the Risk and Severity of Childhood Onset Schizophrenia of Schizophrenia Risk Genetic Variants at the DRD2 and ZNF804A Loci. Child psychiatry and human development 2021 Sep . Alfimova Margarita V, Nikitina Svetlana G, Lezheiko Tatyana V, Simashkova Nataliya V, Golimbet Vera |
Genetic underpinnings of sociability in the general population.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2021 May . Bralten Janita, Mota Nina R, Klemann Cornelius J H M, De Witte Ward, Laing Emma, Collier David A, de Kluiver Hilde, Bauduin Stephanie E E C, Arango Celso, Ayuso-Mateos Jose L, Fabbri Chiara, Kas Martien J, van der Wee Nic, Penninx Brenda W J H, Serretti Alessandro, Franke Barbara, Poelmans Gee |
| Genetic Variants Allegedly Linked to Antisocial Behaviour Are Equally Distributed Across Different Populations. Journal of personalized medicine 2021 Mar 11 (3): . Zampatti Stefania, Ragazzo Michele, Fabrizio Carlo, Termine Andrea, Campoli Giulia, Caputo Valerio, Strafella Claudia, Cascella Raffaella, Caltagirone Carlo, Giardina Emilia |
| Negative symptoms in schizophrenia: correlation with clinical and genetic factors. Pharmacogenomics 2021 4 22 (7): 389-399. Hajj Aline, Hallit Souheil, Chamoun Karam, Sacre Hala, Obeid Sahar, Haddad Chadia, Dollfus Sonia, Khabbaz Lydia Rabb |
| The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia. Genes 2022 7 13 (8): . Paderina Diana Z, Boiko Anastasiia S, Pozhidaev Ivan V, Mednova Irina A, Goncharova Anastasia A, Bocharova Anna V, Fedorenko Olga Yu, Kornetova Elena G, Semke Arkadiy V, Bokhan Nikolay A, Loonen Anton J M, Ivanova Svetlana |
| A polygenic score indexing a DRD2-related co-expression network is associated with striatal dopamine function. Scientific reports 2022 7 12 (1): 12610. D'Ambrosio Enrico, Pergola Giulio, Pardiñas Antonio F, Dahoun Tarik, Veronese Mattia, Sportelli Leonardo, Taurisano Paolo, Griffiths Kira, Jauhar Sameer, Rogdaki Maria, Bloomfield Michael A P, Froudist-Walsh Sean, Bonoldi Ilaria, Walters James T R, Blasi Giuseppe, Bertolino Alessandro, Howes Oliver |
| Dopamine DRD2 and DRD3 Polymorphisms Involvement in Nicotine Dependence in Patients with Treatment-Resistant Mental Disorders. Journal of personalized medicine 2022 4 12 (4): . Del Casale Antonio, Paolini Marco, Gentile Giovanna, Borro Marina, Zocchi Clarissa, Fiaschè Federica, Padovano Alessio, Zoppi Teodolinda, Modesti Martina Nicole, De Luca Ottavia, Pomes Leda Marina, Brugnoli Roberto, Ferracuti Stefano, Girardi Paolo, Pompili Maurizio, Simmaco Mauriz |
| Polymorphisms in Schizophrenia-Related Genes Are Potential Predictors of Antipsychotic Treatment Resistance and Refractoriness. The international journal of neuropsychopharmacology 2022 4 25 (9): 701-708. Zazueta Alejandra, Castillo Tito, Cavieres Álvaro, González René, Abarca Maximiliano, Nieto Rodrigo R, Deneken Javier, Araneda Cristian, Moya Pablo R, Bustamante M Leon |
| Antipsychotic drug-aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphisms. Pharmacological reports : PR 2022 12 75 (1): 19-31. Stelmach Adriana, Guzek Katarzyna, Ro?nowska Alicja, Najbar Irena, Sadakierska-Chudy An |
| The ANKK1/DRD2 gene TaqIA polymorphism (rs1800497) is associated with the severity of extrapyramidal side effects of haloperidol treatment in CYP2D6 extensive metabolizers with schizophrenia spectrum disorders. Drug metabolism and personalized therapy 2022 11 . Kibitov Andrey Alexandrovitch, Kiryanova Elena Mikhaylovna, Salnikova Ludmila Ivanovna, Bure Irina Vladimirovna, Shmukler Alexander Borisovitch, Kibitov Alexander Olegovit |
| The Role of Dopaminergic Genes in Probabilistic Reinforcement Learning in Schizophrenia Spectrum Disorders. Brain sciences 2021 Dec 12 (1): . Frydecka Dorota, Misiak B?a?ej, Piotrowski Patryk, Bielawski Tomasz, Pawlak Edyta, K?osi?ska Ewa, Krefft Maja, Al Noaimy Kamila, Rymaszewska Joanna, Moustafa Ahmed A, Drapa?a Jaros? |
| DRD2, DRD3, and HTR2A Single-Nucleotide Polymorphisms Involvement in High Treatment Resistance to Atypical Antipsychotic Drugs. Biomedicines 2023 7 11 (7): . Antonio Del Casale, Maurizio Simmaco, Martina Nicole Modesti, Clarissa Zocchi, Jan Francesco Arena, Irene Bilotta, Alessandro Alcibiade, Giuseppe Sarli, Lorenzo Cutillo, Giulia Antonelli, Enrico La Spina, Ottavia De Luca, Robert Preissner, Marina Borro, Giovanna Gentile, Paolo Girardi, Maurizio Pompi |
| Functional single nucleotide polymorphisms in dopaminergic receptors D2 predict clinical response to Cariprazine. Frontiers in pharmacology 2023 5 14 1182393. Marco De Pieri, Marco Ferrari, Franca Marino, Rafael Traber, Emilio Bolla, Marco Cosenti |
| Association of DRD2, DRD4 and COMT genes variants and their gene-gene interactions with antipsychotic treatment response in patients with schizophrenia. BMC psychiatry 2023 10 23 (1): 781. Narges Taheri, Rokhshid Pirboveiri, Mehdi Sayyah, Mahdi Bijanzadeh, Pegah Ghand |
| Association Study Between DRD2, DRD3 Genetic Polymorphisms and Adverse Reactions in Chinese Patients on Amisulpride Treatment. Pharmacopsychiatry 2024 8 . Kankan Qu, Yanan He, Zhongdong Zhang, Yeli Cao, Qiyun Qin, Zhenhe Zhou, Lili Zh |
| Genome-wide association exploratory studies in individuals with ultra-high risk for schizophrenia in Chinese Han nationality in two years follow-up: A subpopulation study. Asian journal of psychiatry 2024 5 97 104071. Fei Wang, Zhuo-Hui Huang, Ye Ye, Xiao-Yan He, Shi-Bin Wang, Fu-Jun Jia, Cai-Lan H |
- Page last reviewed:Feb 1, 2024
- Content source: